Literature DB >> 9270603

Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease.

H Rosenmann1, Z Meiner, E Kahana, M Halimi, E Lenetsky, O Abramsky, R Gabizon.   

Abstract

The 14-3-3 protein, a protein involved in signal transduction, is present in the CSF of patients with Creutzfeldt-Jakob disease (CJD) and not in patients with other dementing diseases. We show here that this is also true for patients with E200K CJD, but not for healthy carriers of the mutation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270603     DOI: 10.1212/wnl.49.2.593

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.

Authors:  Zeev Meiner; Esther Kahana; Fanny Baitcher; Amos D Korczyn; Joab Chapman; Oren S Cohen; Ron Milo; Judith Aharon-Perez; Oded Abramsky; Ruth Gabizon; Hanna Rosenmann
Journal:  J Neurol       Date:  2010-09-09       Impact factor: 4.849

2.  Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

Authors:  Natividad Cuadrado-Corrales; Adolfo Jiménez-Huete; Carmen Albo; Rafael Hortigüela; Luz Vega; Laura Cerrato; Maríajosé Sierra-Moros; Alberto Rábano; Jesús de Pedro-Cuesta; Miguel Calero
Journal:  BMC Neurol       Date:  2006-07-26       Impact factor: 2.474

3.  Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients.

Authors:  Bo-Yeong Choi; Su Yeon Kim; So-Young Seo; Seong Soo A An; Sangyun Kim; Sang-Eun Park; Seung-Han Lee; Yun-Ju Choi; Sang-Jin Kim; Chi-Kyeong Kim; Jun-Sun Park; Young-Ran Ju
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.